Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa

Tropical Medicine and International Health

Volumn 21, Issue 7, 2016, Pages 829-845

  le Roux, Stanzi M ^a   Abrams, Elaine J ^b,c   Nguyen, Kelly ^a   Myer, Landon ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Department of Medicine   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Africa; HIV; infant; Maternal Health; prevention; sub Saharan

Indexed keywords

BREASTFEEDING; CHILD HEALTH; CHILD MORTALITY; DISEASE CONTROL; DISEASE TRANSMISSION; DISEASE TREATMENT; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; MATERNAL HEALTH; MORBIDITY;

AFRICA; BREAST FEEDING; CHILD; CINAHL; EMBASE; EXPOSURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LONGITUDINAL STUDY; MATERNAL WELFARE; MEDLINE; MORBIDITY; MORTALITY RISK; PSYCINFO; PUBLIC HEALTH; STUDY DESIGN; SYSTEMATIC REVIEW;

SUB-SAHARAN AFRICA;

EID: 84977517887     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12716     Document Type: Review

References (122)

1. UNAIDS. How AIDS changed everything. MDG 6: 15 years, 15 lessons of hope from the AIDS response. 2014 (Available from: http://www.unaids.org/sites/default/files/media_asset/MDG6Report_en.pdf) [17 Aug 2015].
2. Sugandhi N, Rodrigues J, Kim M et al. HIV-exposed infants: rethinking care for a lifelong condition. AIDS 2013: 27 (Suppl. 2): S187–S195.
3. Kuhn L, Thea DM, Aldrovandi GM. Bystander effects: children who escape infection but not harm. J Acquir Immune Defic Syndr 2007: 46: 517–518.
4. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health 2009: 14: 276–287.
5. Koyanagi A, Humphrey JH, Ntozini R et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011: 30: 45–51.
6. Cotton MF, Slogrove A, Rabie H. Infections in HIV-exposed uninfected children with focus on sub-Saharan Africa. Pediatr Infect Dis J 2014: 33: 1085–1086.
7. Kuhn L, Kasonde P, Sinkala M et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005: 41: 1654–1661.
8. Bates I, Fenton C, Gruber J et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis 2004: 4: 267–277.
9. Reikie BA, Naidoo S, Ruck CE et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol 2013: 20: 33–38.
10. Abramczuk BM, Mazzola TN, Moreno YM et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011: 18: 1406–1409.
11. Mazzola TN, da Silva MT, Abramczuk BM et al. Impaired Bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011: 25: 2079–2087.
12. Jones C, Pollock L, Barnett SM, Battersby A, Kampmann B. Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open 2013: 3(4) pii e002473.
13. Ndirangu J, Barnighausen T, Tanser F, Tint K, Newell ML. Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa. Trop Med Int Health 2009: 14: 1383–1393.
14. Gompels UA, Larke N, Sanz-Ramos M et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 2012: 54: 434–442.
15. Epalza C, Goetghebuer T, Hainaut M et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010: 126: e631–e638.
16. Mermin J, Were W, Ekwaru JP et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 2008: 371: 752–759.
17. Rollins NC, Becquet R, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS 2008;22: 2349–2357.
18. Arpadi S, Fawzy A, Aldrovandi GM et al. Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr 2009: 90: 344–353.
19. Fawzy A, Arpadi S, Kankasa C et al. Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis 2011: 203: 1222–1230.
20. Kuhn L, Aldrovandi G. Pendulum swings in HIV-1 and infant feeding policies: now halfway back. Adv Exp Med Biol 2012: 743: 273–287.
21. Kuhn L, Stein Z, Susser M. Preventing mother-to-child HIV transmission in the new millennium: the challenge of breast feeding. Paediatr Perinat Epidemiol 2004: 18: 10–16.
22. Lunney KM, Jenkins AL, Tavengwa NV et al. HIV-positive poor women may stop breast-feeding early to protect their infants from HIV infection although available replacement diets are grossly inadequate. J Nutr 2008: 138: 351–357.
23. World Health Organization (WHO). Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection. World Health Organization: Geneva, Switzerland, 2013.
24. Department of Health RoSA. The South African Antiretroviral Treatment Guidelines 2013 (PMTCT guidelines revised March 2013). 2013.
25. The South African Antiretroviral Treatment Guidelines. South African Department of Health. 2013. (Available from: http://www.sahivsoc.org/upload/documents/2013%20ART%20Guidelines-Short%20Combined%20FINAL%20draft%20guidelines%2014%20March%202013.pdf) [14 Sep 2015]
26. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.
27. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database of Syst Rev. 2010: Cd008440. (Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008440/abstract) [14 Sep 2015]
28. Spaulding A, Rutherford GW, Siegfried N. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naive individuals. Cochrane Database of Syst Rev. 2010: Cd008740. (Available from: http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD008740/) [14 Sep 2015]
29. Ndirangu J, Newell ML, Thorne C, Bland R. Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa. Antivir Ther 2012: 17: 81–90.
30. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011;305: 576–584.
31. de Deus N, Moraleda C, Serna-Bolea C, Renom M, Menendez C, Naniche D. Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique. BMC Infect Dis 2015: 15: 37.
32. Ramokolo V, Lombard C, Fadnes LT et al. HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants. J Nutr 2014: 144: 42–48.
33. Patel D, Bland R, Coovadia H, Rollins N, Coutsoudis A, Newell ML. Breastfeeding, HIV status and weights in South African children: a comparison of HIV-exposed and unexposed children. AIDS 2010: 24: 437–445.
34. Liu L, Johnson HL, Cousens S et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012: 379: 2151–2161.
35. Horta BL, de Mola CL, Victora CG. Breastfeeding and intelligence: systematic review and meta-analysis. Acta Paediatr. 2015: 104(467): 14–19.
36. Lamberti LM, Fischer Walker CL, Noiman A, Victora C, Black RE. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011: 11 (Suppl. 3): S15.
37. Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013: 13(Suppl. 3): S18.
38. Rollins N, Mahy M, Becquet R, Kuhn L, Creek T, Mofenson L. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 2012: 88(Suppl. 2): i44–i51.
39. WHO. Breastfeeding and replacement feeding practices in the context of mother-to-child transmission of HIV. An assessment tool for research. 2001. (Available from: http://apps.who.int/iris/bitstream/10665/67132/1/WHO_CAH_01.21.pdf?ua=1&ua=1) [09 May 2016]
40. WHO. WHO Guidelines on HIV and Infant Feeding 2010. An updated framework for priority action. 2010. (Available from: http://www.who.int/maternal_child_adolescent/documents/9789241599535/en/) [14 Sep 2015]
41. Alvarez-Uria G, Midde M, Pakam R, Bachu L, Naik PK. Effect of formula feeding and breastfeeding on child growth, infant mortality, and hiv transmission in children born to HIV-infected pregnant women who received triple antiretroviral therapy in a resource-limited setting: data from an HIV cohort study in India. ISRN Pediatr 2012: 2012: 763591.
42. Blystad A, van Esterik P, de Paoli MM, Sellen DW, Leshabari SC, Moland KM. Reflections on global policy documents and the WHO's infant feeding guidelines: lessons learnt. Int Breastfeed J 2010: 5: 18.
43. Kafulafula G, Hoover DR, Taha TE et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010: 53: 6–13.
44. Thior I, Lockman S, Smeaton LM et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006: 296: 794–805.
45. Kuhn L, Aldrovandi GM, Sinkala M et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008: 359: 130–141.
46. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Syst Rev 2011: Cd003510. (Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003510.pub3/abstract) [14 Sep 2015]
47. Shapiro RL, Kitch D, Ogwu A et al. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana. AIDS 2013: 27: 1911–1920.
48. Chasela CS, Hudgens MG, Jamieson DJ et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010: 362: 2271–2281.
49. The Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers and Children (IATT). Option B+ countries and PMTCT regimen 2015 [16 Aug 2015].
50. Natchu UC, Liu E, Duggan C et al. Exclusive breastfeeding reduces risk of mortality in infants up to 6 mo of age born to HIV-positive Tanzanian women. Am J Clin Nutr 2012: 96: 1071–1078.
51. Rudan I, O'Brien KL, Nair H et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013: 3: 10401.
52. Walker SP, Wachs TD, Grantham-McGregor S et al. Inequality in early childhood: risk and protective factors for early child development. Lancet 2011: 378: 1325–1338.
53. Black RE, Victora CG, Walker SP et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013: 382: 427–451.
54. Marquez C, Okiring J, Chamie G et al. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr 2014: 60: 434–441.
55. Liu L, Oza S, Hogan D et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015: 385: 430–440.
56. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015: 385: 117–171.
57. WHO. Health for the world's adolescents. A second chance in the second decade. 2014. (Available from: http://apps.who.int/adolescent/second-decade/) [1 Nov 2015]
58. Powis K, editor No Free Rides: Consequences of Fetal & Infant ARV Exposure Among Children Remaining HIV Uninfected. Conference on Retroviruses and Opportunistic Infections; 2014 3–6 March 2014; Boston, Massachusetts.
59. Abubakar A, Van Baar A, Van de Vijver FJ, Holding P, Newton CR. Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review. Trop Med Int Health 2008: 13: 880–887.
60. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol 2014: 176: 11–22.
61. Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr 2011: 57: 290–296.
62. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutr Rev 2009: 67: 343–359.
63. Jao J, Abrams EJ. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr Infect Dis J 2014: 33: 734–740.
64. Kellerman SE, Ahmed S, Feeley-Summerl T et al. Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive. AIDS 2013: 27 (Suppl. 2): S225–S233.
65. Le Doare K, Bland R, Newell ML. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 2012: 130: e1326–e1344.
66. Newell ML, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Curr Opin HIV AIDS 2013: 8: 504–510.
67. Sherr L, Cluver LD, Betancourt TS, Kellerman SE, Richter LM, Desmond C. Evidence of impact: health, psychological and social effects of adult HIV on children. AIDS 2014: 28 (Suppl. 3): S251–S259.
68. Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review. J Int AIDS Soc 2013: 16: 18865.
69. Shapiro RL, Lockman S. Mortality among HIV-exposed infants: the first and final frontier. Clin Infect Dis 2010: 50: 445–447.
70. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010: 25: 603–605.
71. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org
72. Sterne J, Higgins J, Reeves B, on behalf of the development group for ACROBAT-NRSI. A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI) 2014. (Available from: www.riskofbias.info) [17 Mar 2016]
73. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002: 21: 1539–1558.
74. Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract 2008: 14: 951–957.
75. Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008: 336: 1413–1415.
76. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006: 25: 3443–3457.
77. Ota MO, O'Donovan D, Alabi AS et al. Maternal HIV-1 and HIV-2 infection and child survival in The Gambia. AIDS 2000: 14: 435–439.
78. Schim Van Der Loeff MF, Hansmann A, Awasana AA et al. Survival of HIV-1 and HIV-2 perinatally infected children in the Gambia. AIDS 2003: 17: 2389–2394.
79. Bagenda D, Nassali A, Kalyesubula I et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics 2006: 117: 729–740.
80. Drotar D, Olness K, Wiznitzer M et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics 1997: 100: E5.
81. Filteau S, Baisley K, Chisenga M, Kasonka L, Gibson RS. Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed uninfected Zambian children to catch up in growth to HIV-unexposed children: a randomized controlled trial. J Acquir Immune Defic Syndr 2011: 56: 166–175.
82. Nicholson L, Chisenga M, Siame J, Kasonka L, Filteau S. Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy. BMC Pediatr 2015: 15: 66.
83. Taha TE, Graham SM, Kumwenda NI et al. Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics 2000: 106: E77.
84. Marinda E, Humphrey JH, Iliff PJ et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007: 26: 519–526.
85. Taha TE, Kumwenda NI, Broadhead RL et al. Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 1999: 18: 689–694.
86. Rollins NC, Ndirangu J, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Exclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South Africa. PLoS One 2013: 8: e81307.
87. Kurewa EN, Kandawasvika GQ, Mhlanga F et al. Realities and challenges of a five year follow up of mother and child pairs on a PMTCT program in Zimbabwe. Open AIDS J 2011: 5: 51–58.
88. Kandawasvika GQ, Ogundipe E, Gumbo FZ, Kurewa EN, Mapingure MP, Stray-Pedersen B. Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe. Dev Med Child Neurol 2011: 53: 1046–1052.
89. Chopra M, Doherty T, Goga A, Jackson D, Persson LA. Survival of infants in the context of prevention of mother to child HIV transmission in South Africa. Acta Paediatr 2010: 99: 694–698.
90. Arinaitwe E, Gasasira A, Verret W et al. The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study. Malar J 2012: 11: 90.
91. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 1999: 28: 532–540.
92. Boivin MJ, Green SD, Davies AG, Giordani B, Mokili JK, Cutting WA. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol 1995: 14: 13–21.
93. Brahmbhatt H, Kigozi G, Wabwire-Mangen F et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006: 41: 504–508.
94. Chilongozi D, Wang L, Brown L et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008: 27: 808–814.
95. Luabeya KK, Mpontshane N, Mackay M et al. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS One 2007: 2: e541.
96. Marquez C, Okiring J, Chamie G et al. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr 2014: 60: 434–441.
97. Moraleda C, de Deus N, Serna-Bolea C et al. Impact of HIV exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2014: 65: 182–189.
98. Muhangi L, Lule SA, Mpairwe H et al. Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda. Public Health Nutr 2013: 16: 1548–1557.
99. Naniche D, Bardaji A, Lahuerta M et al. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg 2009: 80: 870–876.
100. Ngoma MS, Hunter JA, Harper JA et al. Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. AIDS 2014: 28(Suppl. 3): S323–S330.
101. Parker ME, Tembo M, Adair L et al. The health of HIV-exposed children after early weaning. Matern Child Nutr 2013: 9: 217–232.
102. Shapiro RL, Lockman S, Kim S et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 2007: 196: 562–569.
103. Sherry B, Embree JE, Mei Z et al. Sociodemographic characteristics, care, feeding practices, and growth of cohorts of children born to HIV-1 seropositive and seronegative mothers in Nairobi, Kenya. Trop Med Int Health 2000: 5: 678–686.
104. Slogrove A, Reikie B, Naidoo S et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012: 58: 505–508.
105. Spira R, Lepage P, Msellati P et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics 1999: 104: e56.
106. Sutcliffe CG, Scott S, Mugala N et al. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis 2008: 47: 837–844.
107. Thea DM, St Louis ME, Atido U et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993: 329: 1696–1702.
108. van Eijk AM, Brooks JT, Adcock PM et al. Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya. Int J Infect Dis 2010: 14: e220–e225.
109. Van Rie A, Dow A, Mupuala A, Stewart P. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 2009: 52: 636–642.
110. Landes M, van Lettow M, Chan AK, Mayuni I, Schouten EJ, Bedell RA. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLoS One 2012: 7: e47337.
111. WHO, UNICEF, USAID, AED, UCDAVIS, IFPRI. Indicators for assessing infant and young child feeding practices. Part I: Definitions. 2008. (Available from: http://www.who.int/nutrition/publications/infantfeeding/9789241596664/en/) [19 July 2015]
112. Humphrey JH, Marinda E, Mutasa K et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 2010: 341: c6580.
113. Bhutta ZA, Ali S, Cousens S et al. Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Lancet 2008: 372: 972–989.
114. Bhutta ZA, Das JK, Rizvi A et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013: 382: 452–477.
115. Santosham M, Chandran A, Fitzwater S, Fischer-Walker C, Baqui AH, Black R. Progress and barriers for the control of diarrhoeal disease. Lancet 2010: 376: 63–67.
116. Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 2015: 16: 495.
117. Central Statistical Office (Zimbabwe) and Macro International Inc. Zimbabwe Demographic and Health Survey, 1994. Central Statistical Office and Macro International Inc.: Calverton, Maryland, 1995.
118. Kerr SJ, Puthanakit T, Vibol U et al. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care 2014: 26: 1327–1335.
119. Mussi-Pinhata MM, Motta F, Freimanis-Hance L et al. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis 2010: 14(Suppl. 3): e176–e182.
120. Paul ME, Chantry CJ, Read JS et al. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Pediatr Infect Dis J 2005: 24: 46–56.
121. Newell ML, Borja MC, Peckham C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 2003: 111: e52–e60.
122. Adler C, Haelterman E, Barlow P, Marchant A, Levy J, Goetghebuer T. Severe infections in HIV-exposed uninfected infants born in a European country. PLoS One 2015: 10: e0135375.